臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

關於TAIR
	計畫說明

瀏覽
	典藏機構
	作者
	題名
	日期
	統計圖表
	機構即時統計
	學術趨勢

消息
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

著作權
	出版社及期刊政策查詢
	TAIR著作權會議記錄

相關連結
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

跳至:
或輸入年份:

從最近的開始

由舊到新排序

顯示項目 2234051-2234075 / 2346473 (共93859頁)
<< < 89358 89359 89360 89361 89362 89363 89364 89365 89366 89367 > >>
每頁顯示[10|25|50]項目

機構	日期	題名	作者
臺大學術典藏	2021-09-01T01:53:41Z	Helicobacter pylori sensitizes TNF-related apoptosisinducing ligand (TRAIL)-mediated apoptosis in human gastric epithelial cells through regulation of FLIP	Lin W.-C.; Tsai H.-F.; Liao H.-J.; Tang C.-H.; Wu Y.-Y.; Hsu P.-I.; ANN-LII CHENG; Hsu P.-N.
臺大學術典藏	2021-09-01T01:53:42Z	Re-evaluating transarterial chemoembolization for the treatment of Hepatocellular Carcinoma: Consensus recommendations and review by an International Expert Panel	ANN-LII CHENG; Amarapurkar D.; Chao Y.; Chen P.-J.; Geschwind J.-F.; Goh K.L.; Han K.-H.; Kudo M.; Lee H.C.; Lee R.-C.; Lesmana L.A.; Lim H.Y.; Paik S.W.; Poon R.T.; Tan C.-K.; Tanwandee T.; Teng G.; Park J.-W.
臺大學術典藏	2021-09-01T01:53:42Z	Clinical characteristics of advanced hepatocellular carcinoma patients with prolonged survival in the era of anti-angiogenic targeted-therapy	Lu L.-C.; Shao Y.-Y.; Chan S.-Y.; Hsu C.-H.; ANN-LII CHENG
臺大學術典藏	2021-09-01T01:53:43Z	CYP19 genetic polymorphism haplotype aasa is associated with a poor prognosis in premenopausal women with lymph node-negative, hormone receptor-positive breast cancer	Kuo S.-H.; Yang S.-Y.; Lien H.-C.; Lo C.; Lin C.-H.; Lu Y.-S.; ANN-LII CHENG; Chang K.-J.; Huang C.-S.
臺大學術典藏	2021-09-01T01:53:43Z	Radiofrequency ablation is superior to ethanol injection in early-stage hepatocellular carcinoma irrespective of tumor size	Lin Z.-Z.; Shau W.-Y.; Hsu C.; Shao Y.-Y.; Yeh Y.-C.; Kuo R.N.-C.; Hsu C.-H.; Yang J.C.-H.; ANN-LII CHENG; Lai M.-S.
臺大學術典藏	2021-09-01T01:53:43Z	Sunitinib versus sorafenib in advanced hepatocellular cancer: Results of a randomized phase III trial	ANN-LII CHENG; Kang Y.-K.; Lin D.-Y.; Park J.-W.; Kudo M.; Qin S.; Chung H.-C.; Song X.; Xu J.; Poggi G.; Omata M.; Lowenthal S.P.; Lanzalone S.; Yang L.; Lechuga M.J.; Raymond E.
臺大學術典藏	2021-09-01T01:53:44Z	Hepatitis B virus reactivation in B-cell lymphoma patients treated with rituximab: Analysis from the Asia Lymphoma Study Group	Kim S.J.; Hsu C.; Song Y.-Q.; Tay K.; Hong X.-N.; Cao J.; Kim J.S.; Eom H.S.; Lee J.H.; Zhu J.; Chang K.-M.; Reksodiputro A.H.; Tan D.; Goh Y.T.; Lee J.; Intragumtornchai T.; Chng W.-J.; ANN-LII CHENG; Lim S.T.; Suh C.; Kwong Y.-L.; Kim W.S.
臺大學術典藏	2021-09-01T01:53:44Z	Clinicopathologic features and responses to radiotherapy of myeloid sarcoma	Chen W.-Y.; Wang C.-W.; Chang C.-H.; Liu H.-H.; Lan K.-H.; Tang J.-L.; Tien H.-F.; Kuo S.-H.; ANN-LII CHENG
臺大學術典藏	2021-09-01T01:53:44Z	Brivanib versus sorafenib as first-line therapy in patients with unresectable, advanced hepatocellular carcinoma: Results from the randomized phase III BRISK-FL study	Johnson P.J.; Qin S.; Park J.-W.; Poon R.T.P.; Raoul J.-L.; Philip P.A.; Hsu C.-H.; Hu T.-H.; Heo J.; Xu J.; Lu L.; Chao Y.; Boucher E.; Han K.-H.; Paik S.-W.; Robles-Avi?a J.; Kudo M.; Yan L.; Sobhonslidsuk A.; Komov D.; Decaens T.; Tak W.-Y.; Jeng L.-B.; Liu D.; Ezzeddine R.; Walters I.; ANN-LII CHENG
臺大學術典藏	2021-09-01T01:53:45Z	Phosphorylated insulin-like growth factor-1 receptor (pIGF1R) is a poor prognostic factor in brain metastases from lung adenocarcinomas	Wu P.-F.; Huang W.-C.; Yang J.C.-H.; Lu Y.-S.; Shih J.-Y.; Wu S.-G.; Lin C.-H.; ANN-LII CHENG
臺大學術典藏	2021-09-01T01:53:45Z	A pilot study of hepatic arterial infusion of chemotherapy for patients with advanced hepatocellular carcinoma who have failed anti-angiogenic therapy	Shao Y.-Y.; Liang P.-C.; Wu Y.-M.; Huang C.-C.; Huang K.-W.; Cheng J.C.; Hsu C.-H.; Hsu C.; ANN-LII CHENG; Lin Z.-Z.
臺大學術典藏	2021-09-01T01:53:45Z	Prognostic factors of metastatic or recurrent esophageal squamous cell carcinoma in patients receiving three-drug combination chemotherapy	Chen W.-W.; Lin C.-C.; Huang T.-C.; ANN-LII CHENG; Yeh K.-H.; Hsu C.-H.
臺大學術典藏	2021-09-01T01:53:46Z	Aspirin antagonizes the cytotoxic effect of methotrexate in lung cancer cells	Yan K.-H.; Lee L.-M.; Hsieh M.-C.; Yan M.-D.; Yao C.-J.; Chang P.-Y.; Chen T.-L.; Chang H.-Y.; ANN-LII CHENG; Lai G.-M.; Chuang S.-E.
臺大學術典藏	2021-09-01T01:53:46Z	Nuclear expression of glioma-associated oncogene homolog 1 and nuclear factor-κb is associated with a poor prognosis of pancreatic cancer	Yang S.-H.; Hsu C.-H.; Lee J.-C.; Tien Y.-W.; Kuo S.-H.; ANN-LII CHENG
臺大學術典藏	2021-09-01T01:53:46Z	Detection of the Helicobacter pylori CagA protein in gastric mucosa-associated lymphoid tissue lymphoma cells: Clinical and biological significance	Kuo S.-H.; Chen L.-T.; Lin C.-W.; Wu M.-S.; Hsu P.-N.; Tsai H.-J.; Chu C.-Y.; Tzeng Y.-S.; Wang H.-P.; Yeh K.-H.; ANN-LII CHENG
臺大學術典藏	2021-09-01T01:53:47Z	Sorafenib enhances radiation-induced apoptosis in hepatocellular carcinoma by inhibiting STAT3	Huang C.-Y.; Lin C.-S.; Tai W.-T.; Hsieh C.-Y.; Shiau C.-W.; ANN-LII CHENG; Chen K.-F.
臺大學術典藏	2021-09-01T01:53:47Z	Bevacizumab with erlotinib as first-line therapy in Asian patients with advanced hepatocellular carcinoma: A multicenter phase II study	Hsu C.-H.; Kang Y.K.; Yang T.-S.; Shun C.-T.; Shao Y.-Y.; Su W.-C.; Sandoval-Tan J.; Chiou T.-J.; Jin K.; Hsu C.; ANN-LII CHENG
臺大學術典藏	2021-09-01T01:53:48Z	Primary central nervous system diffuse large B cell lymphoma transformed from orbital mucosa-associated lymphoid tissue lymphoma: Complete response to combined intrathecal and systemic rituximab	Huang H.-C.; ANN-LII CHENG; Lin C.-W.; Kuo S.-H.
臺大學術典藏	2021-09-01T01:53:48Z	Potentiating the Efficacy of Molecular Targeted Therapy for Hepatocellular Carcinoma by Inhibiting the Insulin-Like Growth Factor Pathway	Ou D.-L.; Lee B.-S.; Chang Y.-C.; Lin L.-I.; Liou J.-Y.; Hsu C.; ANN-LII CHENG
臺大學術典藏	2021-09-01T01:53:48Z	Randomized phase iii study of gemcitabine plus S-1, S-1 alone, or gemcitabine alone in patients with locally advanced and metastatic pancreatic cancer in Japan and Taiwan: Gest study	Ueno H.; Ioka T.; Ikeda M.; Ohkawa S.; Yanagimoto H.; Boku N.; Fukutomi A.; Sugimori K.; Baba H.; Yamao K.; Shimamura T.; Sho M.; Kitano M.; ANN-LII CHENG; Mizumoto K.; Chen J.-S.; Furuse J.; Funakoshi A.; Hatori T.; Yamaguchi T.; Egawa S.; Sato A.; Ohashi Y.; Okusaka T.; Tanaka M.
臺大學術典藏	2021-09-01T01:53:48Z	No evidence of IGH-MALT1-translocation in the Ma-1 cell line-A reply	Kuo S.-H.; Weng W.-H.; Yeh K.-H.; Chen L.-T.; ANN-LII CHENG
臺大學術典藏	2021-09-01T01:53:49Z	Targeting epidermal growth factor receptor/human epidermal growth factor receptor 2 signalling pathway by a dual receptor tyrosine kinase inhibitor afatinib for radiosensitisation in murine bladder carcinoma	Tsai Y.-C.; Yeh C.-H.; Tzen K.-Y.; Ho P.-Y.; Tuan T.-F.; Pu Y.-S.; ANN-LII CHENG; Cheng J.C.-H.
臺大學術典藏	2021-09-01T01:53:49Z	Hospital volume of percutaneous radiofrequency ablation is closely associated with treatment outcomes for patients with hepatocellular carcinoma	Lu L.-C.; Shao Y.-Y.; Kuo R.N.C.; Lin Z.-Z.; Yeh Y.-C.; Shau W.-Y.; Hsu C.-H.; ANN-LII CHENG; Lai M.-S.
臺大學術典藏	2021-09-01T01:53:50Z	Clinical significance of ESR1 gene copy number changes in breast cancer as measured by fluorescence in situ hybridisation	Lin C.-H.; Liu J.M.; Lu Y.-S.; Lan C.; Lee W.-C.; Kuo K.-T.; Wang C.-C.; Chang D.-Y.; Huang C.-S.; ANN-LII CHENG
臺大學術典藏	2021-09-01T01:53:50Z	Cancerous Inhibitor of Protein Phosphatase 2A Mediates Bortezomib-Induced Autophagy in Hepatocellular Carcinoma Independent of Proteasome	Yu H.-C.; Hou D.-R.; Liu C.-Y.; Lin C.-S.; Shiau C.-W.; ANN-LII CHENG; Chen K.-F.

顯示項目 2234051-2234075 / 2346473 (共93859頁)
<< < 89358 89359 89360 89361 89362 89363 89364 89365 89366 89367 > >>
每頁顯示[10|25|50]項目

	English \| 正體中文 \| 简体中文 \| 總筆數 :2853537
	造訪人次 : 45264875 線上人數 : 797 教育部委託研究計畫計畫執行:國立臺灣大學圖書館